会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • METABOLIC ENGINEERING OF A GALACTOSE ASSIMILATION PATHWAY IN THE GLYCOENGINEERED YEAST PICHIA PASTORIS
    • 葡萄糖生物化学烟草中糖基化途径的代谢工程
    • US20120003695A1
    • 2012-01-05
    • US13202002
    • 2010-02-24
    • Robert C. DavidsonPiotr BobrowiczDongxing Zha
    • Robert C. DavidsonPiotr BobrowiczDongxing Zha
    • C12P21/00C12N9/64C12N15/81C12N9/16C12N9/24C12N1/19C12N9/72
    • C12P21/005C07K16/32C07K2317/14C07K2317/41C12N1/16C12N9/1205C12N9/1241C12N9/90C12N15/815
    • Lower eukaryotic cells such as Pichia pastoris that normally cannot use galactose as a carbon source but which have been genetically engineered according to the methods herein to use galactose as a sole source of carbon are described. The cells are genetically engineered to express several of the enzymes comprising the Leloir pathway. In particular, the cells are genetically engineered to express a galactokinase, a UDP-galactose-C4-epimerase, and a galactose-1-phosphate uridyltransferase, and optionally a galactose permease. In addition, a method is provided for improving the yield of glycoproteins that have galactose-terminated or -containing N-glycans in cells that have been genetically engineered to produce glycoproteins with N-glycans having galactose residues but which normally lack the enzymes comprising the Leloir pathway comprising transforming the cells with one or more nucleic acid molecules encoding a galactokinase, a UDP-galactose-C4-epimerase, and a galactose-1-phosphate uridyltransferase. The methods and host cells described enable the presence or lack of the ability to assimilate galactose as a selection method for making recombinant cells. The methods and host cells are shown herein to be particularly useful for making immunoglobulins and the like that have galactose-terminated or containing N-glycans.
    • 描述了通常不能使用半乳糖作为碳源但已经根据本文的方法进行遗传工程化的低等真核细胞,例如巴斯德毕赤酵母,其使用半乳糖作为唯一的碳源。 细胞被遗传工程化以表达几种包含Leloir途径的酶。 特别地,细胞被遗传工程化以表达半乳糖激酶,UDP-半乳糖-C4差向异构酶和半乳糖-1-磷酸尿苷酸转移酶,以及任选的半乳糖通透酶。 此外,提供了一种用于提高具有半乳糖封端或含有N-聚糖的糖蛋白的产率的方法,所述糖蛋白在已被遗传工程化以产生具有半乳糖残基的N-聚糖的糖蛋白的细胞中,但通常缺少包含Leloir的酶 途径包括用编码半乳糖激酶,UDP-半乳糖-C4-差向异构酶和半乳糖-1-磷酸尿苷转移酶的一种或多种核酸分子转化细胞。 所描述的方法和宿主细胞使得存在或缺乏同化半乳糖的能力作为制备重组细胞的选择方法。 本文显示的方法和宿主细胞特别可用于制备具有半乳糖终止或含有N-聚糖的免疫球蛋白等。